Albert-Ludwigs-Universität Freiburg

Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry (2021) Kuemmerle-Deschner J, Henes J, Kortus-Goetze B, Kallinich T, Oommen PT, Rech J, Weller-Heinemann F, et al. Conference contribution Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients (2021) Rech J, Hueber A, Ostergaard M, Tascilar K, Hagen M, Mendez LV, Kleyer A, et al. Conference contribution Secukinumab in Giant Cell Arteritis: A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase 2 Trial (2021) Venhoff N, Schmidt W, Bergner R, Rech J, Unger L, Tony HP, Mendelson M, et al. Conference contribution Humoral Immune Responses to SARS-CoV2 Infections and upon Vaccination Against SARS-CoV2 (2021) Finzel S, Peter N, Brand C, Fischer B, Keller B, Weigang S, Kochs G, et al. Conference contribution SOMATIC GENETIC RESCUE IN SAMD9/SAMD9L MDS PREDISPOSITION SYNDROMES (2021) Sahoo S, Pastor V, Goodings C, Noellke P, Dworzak M, Stary J, Locatelli F, et al. Conference contribution Launch of a national candidemia surveillance network in Germany (2021) Aldejohann AM, Reinhardt M, Martin R, Walther G, Elias J, Haas A, Hamprecht A, et al. Conference contribution Self-Reported Medication Use and Urinary Drug Metabolites in the German Chronic Kidney Disease (GCKD) Study (2021) Kotsis F, Schultheiss UT, Wuttke M, Schlosser P, Mielke J, Becker MS, Oefner PJ, et al. Journal article Editorial: Wearable and Implantable Technologies in the Rehabilitation of Patients With Sensory Impairments (2021) Pasluosta CF, Popovic MR, Eskofier B, Stieglitz T Journal article, Editorial β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression (2021) Hofbauer D, Mougiakakos D, Broggini L, Zaiss M, Büttner-Herold M, Bach C, Spriewald B, et al. Journal article Degarelix for treating advanced hormone-sensitive prostate cancer (2021) Zengerling F, Jakob JJ, Schmidt S, Meerpohl JJ, Blumle A, Schmucker C, Mayer B, Kunath F Journal article